California medtech maker Accuray (NSDQ:ARAY) tallied a win in a trade secrets lawsuit filed by a former supplier, announcing that a Minnesota court awarded summary judgment against Rotary Systems.
TomoTherapy Inc.
Teleflex taps former Tomotherapy CFO Powell as finance chief | Personnel Roundup
Teleflex (NYSE:TFX) named Thomas Powell CFO effective March 9, replacing Richard Meier, who was ousted the same day.
Powell joined the Limerick, Pa.-based device maker last year as senior vice president of global finance, according to regulatory filings, prior to which he was CFO of TomoTherapy, which was subsequently sold to Accuray (NSDQ:ARAY).
Accuray and Siemens amend ties amid tough times
Accuray to cut workforce by 5%
Accuray slips into the red in Q4, FY2011 | Earnings Roundup
Accuray Inc. (NSDQ:ARAY) may be the fish that swallowed the whale, but it might have bitten off more than it can chew judging from its fourth-quarter and fiscal 2011 results.
The Sunnyvale, Calif.-based radiosurgery device maker paid $300 million for its larger rival TomoTherapy in March. That acquisition sent ARAY into the red for both the quarter and full year.
Accuray closes $277 million TomoTherapy merger
Toshiba takes one step closer to $273 Vital Images acquisition | Acquisitions roundup
Toshiba Medical Systems Corp. came one step closer the $273 million acquisition of Vital Images Inc. (NSDQ:VTAL) with the announcement that the initial tender offer period had expired.
A total of 11.9 million shares were tendered by expiration time, representing about 72 percent of Vital Images’ outstanding common stock on a fully diluted basis.
St. Jude Medical puts more skin in iRhythm Technologies| Acquisitions roundup
St. Jude Medical’s (NYSE:STJ) partnership with a California-based arrhythmia-diagnostic company is going well enough that it recently poured more money into that startup.
GE Healthcare snaps up cellular imaging firm | Acquisitions roundup
GE Healthcare is looking to boost its life sciences portfolio with the acquisition of a cellular imaging firm.
The General Electric Co. (NYSE:GE) unit is planning to buy Seattle area Applied Precision Inc. in a bid to expand its research products and services offering for the pharmaceutical and life science industries, the company said.
